Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» oncology
oncology
Bayer nabs yet another oncology leader from GSK to bolster cancer efforts
Fierce Biotech
Fri, 04/22/22 - 10:34 am
Bayer
GSK
oncology
Gilead, after setbacks, aims to pull a third of its revenue from oncology business by 2030
Fierce Pharma
Mon, 04/18/22 - 11:47 pm
Gilead Sciences
oncology
cancer
Yescarta
Trodelvy
BMS-Sponsored Diversity in Oncology Series Tackles Representation in Clinical Trials
BioSpace
Fri, 04/8/22 - 10:42 am
Bristol Myers Squibb
oncology
diversity
clinical trial diversity
In major shake-up, Novartis combines pharma and oncology units, leaving 3 top execs without jobs
Fierce Pharma
Mon, 04/4/22 - 11:00 am
Novartis
layoffs
oncology
restructuring
Sanofi Commits Potential $6B to IGM (Antibodies) in New Collab
BioSpace
Tue, 03/29/22 - 10:53 am
Sanofi
IGM Biosciences
oncology
immunology
antibodies
drug discovery
cancer
4D Pharma: New data early indication LBPs may help to overcome resistance to checkpoint inhibitors
Biopharma Reporter
Tue, 03/29/22 - 10:49 am
4D Pharma
live biotherapeutics
cancer
oncology
AACR Preview: AstraZeneca to Showcase "Oncology Revolution"
BioSpace
Mon, 03/28/22 - 07:48 pm
AstraZeneca
oncology
AACR
Bristol Myers lands $1.1B biobucks oncology pact with Volastra, a biotech with phones 'ringing off the hook'
Fierce Biotech
Mon, 03/21/22 - 10:06 am
Volastra
chromosomal instability
Bristol Myers Squibb
cancer
oncology
funding
Precision oncology startup AnHeart Therapeutics co-founder shares cancer drug strategy
MedCity News
Mon, 03/21/22 - 10:05 am
AnHeart Therapeutics
cancer
oncology
precision oncology
precision medicine
Four Cancer Clinical Trials Advance with Blessing of FDA
BioSpace
Wed, 03/16/22 - 11:23 pm
cancer
oncology
FDA
clinical trials
Sonnet BioTherapeutics
SON-1010
solid tumors
Adagene
AD126
AIM ImmunoTech
Ampligen
pancreatic cancer
Wugen
WU-CART-007
Sanofi steps off the sidelines to ink 3 ADC deal with Seagen, reigniting long-held interest in the modality
Fierce Biotech
Wed, 03/16/22 - 10:38 am
Sanofi
Seagen
antibody-drug conjugate
cancer
oncology
Illumina Unveils Groundbreaking Comprehensive Genomic Profiling Test for Cancer in Europe
BioSpace
Tue, 03/15/22 - 10:45 am
Illumina
Medtech
diagnostics
Europe
TruSight Oncology
cancer
oncology
Digging into biopharma’s big buyout areas
EP Vantage
Fri, 03/11/22 - 10:26 am
M&A
oncology
CNS
Rare Diseases
cancer
Sanofi signals a big interest in oncology as it adds a cancer R&D star to the board
Endpoints
Thu, 02/24/22 - 11:04 pm
Sanofi
oncology
cancer
R&D
Antoine Yver
Centessa
Bristol Myers Squibb, GRYT Health double down on diversity in cancer
Fierce Pharma
Wed, 02/23/22 - 10:28 am
Bristol Myers Squibb
GRYT Health
cancer
oncology
clinical trials
clinical trial diversity
BioNTech and Medigene team up on T cell immunotherapy
Biopharma Reporter
Tue, 02/22/22 - 11:10 pm
BioNTech
Medigene
T-cell immunotherapy
oncology
Merck gets ahead of the Curve, inking oncology and neurology drug discovery deal with emerging British biotech
Fierce Biotech
Wed, 02/16/22 - 10:29 am
Merck
Curve Therapeutics
small molecule drugs
oncology
UK
drug discovery
J&J's Blue Jacket Fashion Show returns live to boost prostate cancer awareness
Fierce Pharma
Tue, 02/15/22 - 10:29 am
pharma marketing
JNJ
Janssen
oncology
prostate cancer
No regrets as Lyell prepares for its first clinical trial
EP Vantage
Mon, 02/7/22 - 11:13 am
Lyell Immunopharma
IPOs
clinical trials
cell therapy
cancer
oncology
Gilead's $4.9B oncology bet hit with partial clinical hold, forcing pause of pivotal trials and raising doubts about CD47
Fierce Biotech
Wed, 01/26/22 - 11:12 am
Gilead Sciences
magrolimab
anti-CD47
FDA
clinical trials
oncology
clinical hold
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »